Skip to main content
FinSpry Logo
FinSpry
QTTB logo
QTTB
(NASDAQ)
Q32 Bio Inc.
$11.95-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Q32 Bio (QTTB) Stock Price & Financial Analysis

Q32 Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.68 - $12.23
52-Week High$14.85
52-Week Low$1.35
Open$11.84
Volume322.16K
Average Volume (3M)1.18M
Market Cap167.73M
Shares Outstanding14.10M
P/E Ratio (TTM)5.05
Price to Sales (P/S)3.12
Price to Book (P/B)3.62
EV/EBITDA5.99
Revenue (TTM)53.74M
Net Income (TTM)33.24M
Free Cash Flow (TTM)-27.40M
EPS (TTM)$2.60
Profit Margin61.86%
Operating Margin39.84%
Return on Equity (ROE)71.78%
Debt to Equity0.34
50-Day MA$8.02
200-Day MA$4.69
52-Week Change646.08%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Q32 Bio

What is the current stock price for QTTB?

As of the latest trading session, QTTB stock trades at $11.16. The 52-week range is $1.35–$14.85, with a day range of $10.68–$12.23.

What is the P/E ratio for QTTB?

Q32 Bio's trailing P/E ratio is 5.0, meaning investors pay $5.0 for every $1 of annual earnings. Q32 Bio operates in the Healthcare sector.

Does QTTB pay dividends?

Q32 Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for QTTB?

Based on 4 analysts, the consensus for QTTB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of QTTB?

Q32 Bio's market capitalization is $157.3M, classifying it as a micro-cap company. Q32 Bio operates in the Healthcare sector within the Biotechnology industry.